Autopsy report · NCT00672633

Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides

“Very slow recruitment.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years 11 months before it stopped.
• 25 participants enrolled.
• Results were posted on the registry 1 year 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Boston Children's Hospital

Sponsor type

University, hospital or other

Conditions

Hypertriglyceridemia

Interventions

Lovaza; Placebo

Participants

25

Sites

1

Countries

United States

Trials that died the same way

• Cardiac Uptake of 18F Florbetapir in Patients Undergoing Chemotherapy
  “slow recruitment.” (95% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.